Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Alopecia Areata”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Testing effectiveness (Phase 2)Study completedNCT02018042
What this trial is testing

An Open-Label Single-Arm Clinical Trial to Evaluate The Efficacy of Abatacept in Moderate to Severe Patch Type Alopecia Areata

Who this might be right for
Alopecia Areata
Columbia University 15
Testing effectiveness (Phase 2)WithdrawnNCT01917058
What this trial is testing

A Clinical Trial to Evaluate the Efficacy of Abatacept in Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Columbia University
Testing effectiveness (Phase 2)Looking for participantsNCT07311564
What this trial is testing

LAD603 in Adults With Alopecia Areata

Who this might be right for
Alopecia Areata
Almirall, S.A. 136
Not applicableNot Yet RecruitingNCT07226531
What this trial is testing

Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US

Who this might be right for
Alopecia Areata
Pfizer 300
Large-scale testing (Phase 3)UnknownNCT05470413
What this trial is testing

Evaluate the Efficacy and Safety of SHR0302 in Adult Patients With Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Reistone Biopharma Company Limited 330
Early research (Phase 1)Active Not RecruitingNCT06545110
What this trial is testing

Retinol Binding Protein 4 Protein in Alopecia Areata Treated With Barcitinib

Who this might be right for
Alopecia Areata
South Valley University 120
Early research (Phase 1)Looking for participantsNCT07205159
What this trial is testing

Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.

Who this might be right for
Alopecia Areata
Forte Biosciences, Inc. 32
Large-scale testing (Phase 3)Study completedNCT05051761
What this trial is testing

Study to Evaluate the Safety and Efficacy of Jaktinib in Adults With Alopecia Areata

Who this might be right for
Alopecia Areata
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 425
Large-scale testing (Phase 3)Study completedNCT05255237
What this trial is testing

Extension Study to Evaluate Safety and Efficacy of Jaktinib in Adults With Alopecia Areata

Who this might be right for
Alopecia Areata
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 315
Testing effectiveness (Phase 2)WithdrawnNCT00746980
What this trial is testing

Efalizumab in the Treatment of Alopecia, Phase II

Who this might be right for
Alopecia Totalis
Northwestern University
Large-scale testing (Phase 3)Study completedNCT05041803
What this trial is testing

European Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata

Who this might be right for
Alopecia Areata
Sun Pharmaceutical Industries, Inc. 407
Testing effectiveness (Phase 2)Study completedNCT02299297
What this trial is testing

Study To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And Universalis

Who this might be right for
Alopecia Areata
Columbia University 12
Testing effectiveness (Phase 2)Study completedNCT04784533
What this trial is testing

Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Concert Pharmaceuticals 317
Large-scale testing (Phase 3)Study completedNCT04797650
What this trial is testing

Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)

Who this might be right for
Alopecia Areata
Concert Pharmaceuticals 517
Not applicableStudy completedNCT00167102
What this trial is testing

Alefacept in Patients With Severe Scalp Alopecia Areata

Who this might be right for
Alopecia Areata
University of Minnesota 45
Post-approval studies (Phase 4)Not Yet RecruitingNCT07406204
What this trial is testing

Tofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)

Who this might be right for
Alopecia AreataAlopecia Totalis (AT)Alopecia Universalis
Hayat Abad Medical Complex, Peshawar 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT06444451
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Adult Participants With Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Sanofi 166
Large-scale testing (Phase 3)Looking for participantsNCT07029828
What this trial is testing

A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.

Who this might be right for
Severe Alopecia Areata
Pfizer 140
Large-scale testing (Phase 3)Study completedNCT03899259
What this trial is testing

Baricitinib (LY3009104) in Adults With Severe or Very Severe Alopecia Areata

Who this might be right for
Alopecia Areata
Eli Lilly and Company 546
Large-scale testing (Phase 3)Looking for participantsNCT07029711
What this trial is testing

Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopecia Areata

Who this might be right for
Severe Alopecia Areata
Pfizer 225
Load More Results